BIG SETBACK FOR DIVI’S LABORATORIES 💊⚠️ DIVISLAB
U.S. President Donald Trump’s strong statement on weight-loss drug pricing has rattled pharma sentiment! 🇺🇸 He hinted at a ~90% price cut in the U.S., aiming to make weight-loss drugs more affordable — a move that could impact global suppliers like Divi’s Labs. Despite broader market positivity, this comment has triggered major concern across the pharma sector.
#StockInNews#WatchOutFor
421 likes·45 comments

















